Dr. Steve J. Schwab (Vice-Chairman, Department of Medicine, Duke University Medical Center, and Professor of Medicine, Duke University School of Medicine, Durham, North Carolina, USA): This case exemplifies the current state of the art for the management of vascular access for hemodialysis. The predominant form of vascular access currently in the United States is the polytetrafluoroethylene (PT...

Nephrologists need to deal with the problem of vascular access management in the same manner as the other major problems that affect our dialysis patients. We need to become experts in vascular access and we need to occupy a pivotal position in directing the decisions that are made that affect dialysis patient welfare. An integrated vascular access management strategy is required. Optimally, th...

A progressive rise in the number of patients accepted for renal replacement therapy has been reported world wide [1]. Permanent vascular access (VA) is the life-line for the majority of these patients, when hemodialysis is the treatment of choice. Thus, the successful creation of permanent vascular access and the appropriate management to decrease the complications is mandatory. A well function...

the number of patients with end-stage renal disease has steadily increased and improvements in hemodialysis techniques have lead to extended life expectancy. pseudoaneurysm is a relatively rare complication of autogenous vascular access. we have reported a case in which an anastomotic pseudoaneurysm developed in a patient on hemodialysis treatment.